Malign Plevral Efuzyonlarin Tedavisi: Britanya Toraks Dernegi Plevral Hastaliklar Rehberi 2010

Roberts, Mark; Neville, E.; Berrisford, Richard; Antunes, George; Ali, Nabeel

doi:10.5152/pb.2011.04

Cited by 3 publications

(18 citation statements)

References 132 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…IPC have been shown to improve dyspnoea scale, reduce length of stay and pain scores when compared with chemical pleurodesis, and are considered the treatment of choice in patients with MPE and suspected or confirmed trapped lung. [1][2][3][4] In addition, IPC may be more cost-effective than chemical pleurodesis in patients with limited survival. 5,6 Decreased or absent pleural fluid drainage through the IPC can be caused by catheter occlusion, catheter not communicating with the fluid collection (e.g.…”

Section: Introductionmentioning

confidence: 99%

Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal

et al. 2020

View full text Add to dashboard Cite

Background and objective: IPC in patients with MPE are removed within 3 months in 30-58% of cases, usually due to decreased pleural fluid output as a result of pleurodesis. Disease control can also account for the lack of fluid output, potentially explaining why 4-14% of patients undergo repeat pleural intervention for fluid re-accumulation (at the time of disease recurrence or progression). The aim of our pilot study is to determine the accuracy of thoracic ultrasound (TUS) in predicting pleurodesis success in patients with MPE at the time of IPC removal. Methods: This is a single-centre, prospective observational cohort study that enrolled consecutive patients with confirmed MPE treated with IPC at the time of IPC removal. TUS was performed to calculate a PAS. Patients were followed up for a minimum of 3 months. Failure was defined as pleural fluid recurrence within 3 months. Results: Twenty-seven patients were screened and 25 were included in the final analysis. Pleurodesis success was observed in 88% (n = 22) and failure in 12% (n = 3) of patients. The mean PAS was higher in patients with pleurodesis success (22.0 vs 9.3, P = 0.01). A PAS greater than 10 predicted pleurodesis success with a sensitivity of 100% and specificity of 86%. Conclusion: This pilot study suggests that TUS at the time of IPC removal accurately identifies patients who have achieved pleurodesis and therefore will not have re-accumulation of pleural effusion or require an ipsilateral pleural intervention for at least 3 months post-IPC removal.

show abstract

Section: Introductionmentioning

confidence: 99%

Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Other underlying causes include: heart failure, kidney diseases, liver cirrhosis, pancreatitis, hypoproteinaemia, fluid overload, trauma, congenital or acquired chylothorax and malignant effusion. Recent international pulmonary guidelines recommend the use of US of the pleura as the main diagnostic method for detection and characterisation of pleural effusion [19][20][21]. Larger effusions are easy to recognize, but very small pleural effusions in the costophrenic recess are sometimes difficult to distinguish from pleural thickening.…”

Section: Pleural Effusionmentioning

confidence: 99%

Ultrasound of the pleura in children, WFUMB review paper

Jaworska¹,

Buda

Ciucă

et al. 2021

Med Ultrason

View full text Add to dashboard Cite

Ultrasound (US) is an ideal diagnostic tool for paediatric patients owning to its high spatial and temporal resolution, real-time imaging, and lack of ionizing radiation and bedside availability. The lack of superficial adipose tissue and favorable acoustic windows in children makes US the first line of investigation for the evaluation of pleural and chest wall abnormali-ties. Lung parenchyma was previously thought to be inaccessible to ultrasound due to the presence of the air and bony thorax. The change in attitude and growing awareness of the diagnostic possibilities has led to lung ultrasound (LUS) being accepted as a valuable point of care method. In addition, the application of LUS has widened with improvements in technology such as higher resolution transducers, harmonic imaging and contrast-enhanced ultrasound. In the current World Federation of Societies for Ultrasound in Medicine and Biology (WFUMB) paper series the topic will be introduced, the technical requirements explained and the use of ultrasound in the lung and pleura in pediatric patients are discussed.

show abstract

“…Pleural effusion complicates many advanced stage intrathoracic and extrathoracic malignancies. The diagnosis of a malignant effusion usually portends as a poor prognosis with an estimated median survival of between 3 and 12 months after diagnosis [1]. Currently, the most common metastatic tumour to the pleura is lung cancer in men and breast cancer in women [1].…”

Section: Introductionmentioning

confidence: 99%

“…The diagnosis of a malignant effusion usually portends as a poor prognosis with an estimated median survival of between 3 and 12 months after diagnosis [1]. Currently, the most common metastatic tumour to the pleura is lung cancer in men and breast cancer in women [1]. Together, both malignancies account for 50-65% of all malignant effusions [1] .…”

Section: Introductionmentioning

confidence: 99%